|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 167.1 USD | -0.44% |
|
+1.52% | +7.87% |
| 05:07pm | AbbVie Says Rinvoq Shows Superiority Versus Dupixent in Atopic Dermatitis Trial Primary Endpoint | MT |
| 12:11pm | Scholz promises support for pharma sector in Germany as Merck invests | RE |
AbbVie said Scott Reents will now serve as senior vice president and chief financial officer. "AbbVie Names Michael President, Reents Finance Chief," at 9:51 a.m. ET on June 28, incorrectly said Mr. Reents was named executive vice president.
(END) Dow Jones Newswires
06-29-22 0635ET
| 1st Jan change | Capi. | |
|---|---|---|
| +7.87% | 297B | |
| +24.17% | 562B | |
| -6.52% | 358B | |
| +19.71% | 322B | |
| +13.45% | 219B | |
| +6.04% | 199B | |
| -10.51% | 196B | |
| -11.88% | 149B | |
| -6.71% | 146B | |
| +2.07% | 117B |
ABBVIE INC. 
